NCT05039567 is a NA clinical trial of optimal heart team protocol in Coronary Artery Disease, sponsored by China National Center for Cardiovascular Diseases.

Who is sponsoring NCT05039567?

NCT05039567 is sponsored by China National Center for Cardiovascular Diseases.

What drugs are being tested in NCT05039567?

Interventions in NCT05039567: optimal heart team protocol.

What condition does NCT05039567 study?

NCT05039567 studies Coronary Artery Disease.

Is NCT05039567 still recruiting?

NCT05039567 is currently completed. Last updated 30 March 2023.

Last reviewed 2023-03-30 · How we verify

NCT05039567

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Optimal Heart Team Protocol on Decision-making Stability

Completed NA Last updated 30 March 2023

What this trial tests

NA trial testing optimal heart team protocol in Coronary Artery Disease in 84 participants. Completed in 28 February 2023.

Timeline

4 January 2022

Primary endpoint
30 December 2022

28 February 2023

Quick facts

Lead sponsor	China National Center for Cardiovascular Diseases
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	84
Start date	4 January 2022
Primary completion	30 December 2022
Estimated completion	28 February 2023
Sites	1 location across China

Drugs / interventions tested

optimal heart team protocol

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

China National Center for Cardiovascular Diseases — full company profile →

Who can join

Adults 18 to 90, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to evaluate the effect of the optimal heart team implementation protocol on the stability of decision-making for patients with complex coronary artery disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of a standardised heart team protocol versus a guideline-based protocol on revascularisation decision stability in stable complex coronary artery disease: rationale and design of a randomised trial of cardiology specialists using historic cases.
Ma H, Lin S, Li X, Wang Y, et al · · 2022 · cited 2× · PMID 36456006 · DOI 10.1136/bmjopen-2022-064761
The modified heart team protocol facilitated the revascularization decision-making quality in complex coronary artery disease.
Ma H, Lin S, Li X, Wang Y, et al · · 2025 · cited 1× · PMID 39932002 · DOI 10.1093/icvts/ivaf023

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other China National Center for Cardiovascular Diseases trials

Trials by the same sponsor.

NCT07514988 — Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment · NA · not yet recruiting
NCT07476456 — Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death · not yet recruiting
NCT07302659 — Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG · NA · recruiting
NCT07482683 — Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach · not yet recruiting
NCT06787430 — Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05039567 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China National Center for Cardiovascular Diseases
Last refreshed: 30 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing